Minimally invasive esophagectomy with hybrid position can be a promising surgical procedure to achieve radical lymphadenectomy with less postoperative complication

Satoru Matsuda; Hirofumi Kawakubo; Shuhei Mayanagi; Tomoyuki Irino; Yuko Kitagawa

doi:10.21037/ales-20-91

Minimally invasive esophagectomy with hybrid position can be a promising surgical procedure to achieve radical lymphadenectomy with less postoperative complication

Satoru Matsuda, Hirofumi Kawakubo, Shuhei Mayanagi, Tomoyuki Irino, Yuko Kitagawa

研究成果: Review article › 査読

本文言語	English
論文番号	91
ジャーナル	Annals of Laparoscopic and Endoscopic Surgery
巻	5
号	October
DOI	https://doi.org/10.21037/ales-20-91
出版ステータス	Published - 2020 10月 20

ASJC Scopus subject areas

外科

文献へのアクセス

10.21037/ales-20-91

他のファイルとリンク

引用スタイル

@article{b35fdc57e7984bf7bccedbc3ffe8df0a,

title = "Minimally invasive esophagectomy with hybrid position can be a promising surgical procedure to achieve radical lymphadenectomy with less postoperative complication",

author = "Satoru Matsuda and Hirofumi Kawakubo and Shuhei Mayanagi and Tomoyuki Irino and Yuko Kitagawa",

note = "Funding Information: ICMJE uniform disclosure form (available at http:// dx.doi.org/10.21037/ales-20-91). Dr. YK reports grants and personal fees from AsahiKASEI Co., Ltd., grants and personal fees from TAIHO PHARMACEUTICAL CO., LTD, grants and personal fees from CHUGAI PHARMACEUTICAL CO., LTD., grants from DAIICHI SANKYO COMPANY, LIMITED, grants from Merck Serono Co., Ltd., grants and personal fees from EA Pharma Co., Ltd., grants and personal fees from Yakult Honsha Co. Ltd., grants and personal fees from Otsuka Pharmaceutical Co., Ltd., grants from Takeda Pharmaceutical Co., Ltd., grants and personal fees from Otsuka Pharmaceutical Factory Inc., grants and personal fees from SHIONOGI & CO., LTD., grants from KAKEN PHARMACEUTICAL CO., LTD., grants from Kowa Pharmaceutical Co., Ltd., grants and personal fees from Astellas Pharma Inc., grants from MEDICON INC., grants and personal fees from DAINIPPON SUMITOMO PHARMA Co., Ltd., grants and personal fees from Taisho Toyama Pharmaceutical Co., Ltd., grants from Kyouwa Hakkou Kirin Co., Ltd., grants from Pfizer Japan Inc., grants and personal fees from ONO PHARMACEUTICAL CO., LTD., grants and personal fees from NIHON PHARMACEUTICAL CO., LTD., grants from Japan Blood Products Organization, grants from Medtronic Japan Co., Ltd., grants and personal fees from Sanofi K.K., grants from Eisai Co., Ltd. , grants from TSUMURA & CO., grants from KCI Licensing, Inc., grants from ABBOTT JAPAN CO., LTD., grants from FUJIFILM Toyama Chemical Co., Ltd., outside the submitted work. The other authors have no conflicts of interest to declare.",

year = "2020",

month = oct,

day = "20",

doi = "10.21037/ales-20-91",

language = "English",

volume = "5",

journal = "Annals of Laparoscopic and Endoscopic Surgery",

issn = "2518-6973",

publisher = "AME Publishing Company",

number = "October",

}

TY - JOUR

T1 - Minimally invasive esophagectomy with hybrid position can be a promising surgical procedure to achieve radical lymphadenectomy with less postoperative complication

AU - Matsuda, Satoru

AU - Kawakubo, Hirofumi

AU - Mayanagi, Shuhei

AU - Irino, Tomoyuki

AU - Kitagawa, Yuko

N1 - Funding Information: ICMJE uniform disclosure form (available at http:// dx.doi.org/10.21037/ales-20-91). Dr. YK reports grants and personal fees from AsahiKASEI Co., Ltd., grants and personal fees from TAIHO PHARMACEUTICAL CO., LTD, grants and personal fees from CHUGAI PHARMACEUTICAL CO., LTD., grants from DAIICHI SANKYO COMPANY, LIMITED, grants from Merck Serono Co., Ltd., grants and personal fees from EA Pharma Co., Ltd., grants and personal fees from Yakult Honsha Co. Ltd., grants and personal fees from Otsuka Pharmaceutical Co., Ltd., grants from Takeda Pharmaceutical Co., Ltd., grants and personal fees from Otsuka Pharmaceutical Factory Inc., grants and personal fees from SHIONOGI & CO., LTD., grants from KAKEN PHARMACEUTICAL CO., LTD., grants from Kowa Pharmaceutical Co., Ltd., grants and personal fees from Astellas Pharma Inc., grants from MEDICON INC., grants and personal fees from DAINIPPON SUMITOMO PHARMA Co., Ltd., grants and personal fees from Taisho Toyama Pharmaceutical Co., Ltd., grants from Kyouwa Hakkou Kirin Co., Ltd., grants from Pfizer Japan Inc., grants and personal fees from ONO PHARMACEUTICAL CO., LTD., grants and personal fees from NIHON PHARMACEUTICAL CO., LTD., grants from Japan Blood Products Organization, grants from Medtronic Japan Co., Ltd., grants and personal fees from Sanofi K.K., grants from Eisai Co., Ltd. , grants from TSUMURA & CO., grants from KCI Licensing, Inc., grants from ABBOTT JAPAN CO., LTD., grants from FUJIFILM Toyama Chemical Co., Ltd., outside the submitted work. The other authors have no conflicts of interest to declare.

PY - 2020/10/20

Y1 - 2020/10/20

UR - http://www.scopus.com/inward/record.url?scp=85106389581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85106389581&partnerID=8YFLogxK

U2 - 10.21037/ales-20-91

DO - 10.21037/ales-20-91

M3 - Review article

AN - SCOPUS:85106389581

SN - 2518-6973

VL - 5

JO - Annals of Laparoscopic and Endoscopic Surgery

JF - Annals of Laparoscopic and Endoscopic Surgery

IS - October

M1 - 91

ER -